The use of myleran in the treatment of chronic myelocytic leukemia.

Suppr

超能文献

作者信息

HAUT A, ALTMAN S J, CARTWRIGHT G E, WINTROBE M M

出版信息

AMA Arch Intern Med. 1955 Oct;96(4):451-62. doi: 10.1001/archinte.1955.00250150025002.

DOI:10.1001/archinte.1955.00250150025002

PMID:13257940

Abstract

摘要

相似文献

The use of myleran in the treatment of chronic myelocytic leukemia.

AMA Arch Intern Med. 1955 Oct;96(4):451-62. doi: 10.1001/archinte.1955.00250150025002.

Myleran in chronic myeloid leukaemia.

Lancet. 1955 Feb 26;268(6861):425-30. doi: 10.1016/s0140-6736(55)90212-9.

Myleran in treatment of chronic myeloid leukaemia.

Br Med J. 1956 Apr 14;1(4971):835-7. doi: 10.1136/bmj.1.4971.835.

Myleran in chronic myeloid leukaemia; results of treatment.

Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.

Treatment of chronic granulocytic leukemia with myleran.

AMA Arch Intern Med. 1956 Mar;97(3):299-308. doi: 10.1001/archinte.1956.00250210045003.

Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

Lancet. 1953 Jan 31;264(6753):207-8. doi: 10.1016/s0140-6736(53)90884-8.

[Casuistics on myleran treatment in chronic myelocytic leukemia].

Arch Kinderheilkd. 1956;153(3):251-4.

[1-4 Dimetanosulfoniloxibutano (GT 41 - myleran) in the treatment of chronic myelogenous leukemia].

Arq Bras Med. 1956 May-Jun;46(5-6):161-72.

Myleran in the treatment of chronic myeloid leukaemia.

Acta Haematol. 1956 Sep;16(3):171-80. doi: 10.1159/000205125.

The treatment of chronic myeloid leukaemia with myleran.

Ir J Med Sci. 1957 Apr(376):186-9. doi: 10.1007/BF02952299.

引用本文的文献

Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.

Exp Hematol. 2022 Jan;105:22-31. doi: 10.1016/j.exphem.2021.11.001. Epub 2021 Nov 8.

Chemotherapy of cancer.

Postgrad Med J. 1958 Dec;34(398):622-7. doi: 10.1136/pgmj.34.398.622.

The chemotherapy of malignant disease.

Br Med J. 1958 Jan 4;1(5061):1-7. doi: 10.1136/bmj.1.5061.1.

Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Br Med J. 1957 Dec 21;2(5059):1468-71. doi: 10.1136/bmj.2.5059.1468.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The use of myleran in the treatment of chronic myelocytic leukemia.

AMA Arch Intern Med. 1955 Oct;96(4):451-62. doi: 10.1001/archinte.1955.00250150025002.

Myleran in chronic myeloid leukaemia.

Lancet. 1955 Feb 26;268(6861):425-30. doi: 10.1016/s0140-6736(55)90212-9.

Myleran in treatment of chronic myeloid leukaemia.

Br Med J. 1956 Apr 14;1(4971):835-7. doi: 10.1136/bmj.1.4971.835.

Myleran in chronic myeloid leukaemia; results of treatment.

Lancet. 1953 Jan 31;264(6753):208-13. doi: 10.1016/s0140-6736(53)90885-x.

Treatment of chronic granulocytic leukemia with myleran.

AMA Arch Intern Med. 1956 Mar;97(3):299-308. doi: 10.1001/archinte.1956.00250210045003.

Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

Lancet. 1953 Jan 31;264(6753):207-8. doi: 10.1016/s0140-6736(53)90884-8.

[Casuistics on myleran treatment in chronic myelocytic leukemia].

Arch Kinderheilkd. 1956;153(3):251-4.

[1-4 Dimetanosulfoniloxibutano (GT 41 - myleran) in the treatment of chronic myelogenous leukemia].

Arq Bras Med. 1956 May-Jun;46(5-6):161-72.

Myleran in the treatment of chronic myeloid leukaemia.

Acta Haematol. 1956 Sep;16(3):171-80. doi: 10.1159/000205125.

The treatment of chronic myeloid leukaemia with myleran.

Ir J Med Sci. 1957 Apr(376):186-9. doi: 10.1007/BF02952299.

引用本文的文献

Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.

Exp Hematol. 2022 Jan;105:22-31. doi: 10.1016/j.exphem.2021.11.001. Epub 2021 Nov 8.

Chemotherapy of cancer.

Postgrad Med J. 1958 Dec;34(398):622-7. doi: 10.1136/pgmj.34.398.622.

The chemotherapy of malignant disease.

Br Med J. 1958 Jan 4;1(5061):1-7. doi: 10.1136/bmj.1.5061.1.

Medullary aplasia in chronic myeloid leukaemia during busulphan therapy.

Br Med J. 1957 Dec 21;2(5059):1468-71. doi: 10.1136/bmj.2.5059.1468.